U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07534046) titled 'Impact of Metabolic Disorders on cACLD Outcomes' on March 10.
Brief Summary: This multicenter, prospective, cohort study is designed to investigate how metabolic disorders (such as obesity, diabetes, and high cholesterol) influence the progression of liver disease in patients with compensated advanced chronic liver disease (cACLD). Chronic liver disease often progresses silently for many years before serious complications like liver failure, cancer, or variceal bleeding develop. While it is known that metabolic problems can accelerate liver damage, current tools for predicting individual risk remain limited. This study aims to enro...